First author, year [reference] | Method | Measure | Results |
Andelid, 2015 [20] | ELISA | IL-17A levels | HNS (n=10) > HS (n=10) > OPD-CB (n=60)# |
Jin, 2014 [21] | ELISA | IL-17A levels | AE-COPD (n=21) > HNS (n=20) > S-COPD (n=23) |
Sun, 2016 [22] | ELISA | IL-17A levels | AE-COPD (n=24) > S-COPD (n=26) = HS (n=23) |
Wang, 2015 [23] | ELISA | IL-17A levels | S-COPD (n=65) > HS (n=35) = HNS (n=31)¶ |
Zhang, 2013 [24] | ELISA | IL-17A levels | S-COPD (n=94) > HS (n=23) = HNS (n=22)§ |
Zhang, 2011 [83] | ELISA | IL-17A levels | HC (n=31) > AE-COPD (n=73) |
Zou, 2017 [25] | ELISA | IL-17A levels | AE-COPD (n=60) > S-COPD (n=60) > HC (n=40) |
Wang, 2015 [23] | ELISA | IL-22 levels | S-COPD (n=65) > HS (n=35) > HNS (n=31)¶ |
Zhang, 2013 [24] | ELISA | IL-22 levels | S-COPD (n=94) = HS (n=23) > HNS (n=22) |
Imani, 2016 [26] | Flow cytometry | IL-17A+ CD4+ T-cells | S-COPD (n=9) > HNS (n=8) |
Li, 2015 [27] | Flow cytometry | IL-17A+ CD4+ T-cells | S-COPD (n=21) = HS (n=21) > HNS (n=21) |
Li, 2014 [28] | Flow cytometry | IL-17A+ CD4+ T-cells | AE-COPD (n=32) > S-COPD (n=36) = HS (n=40) |
Paats, 2012 [29] | Flow cytometry | IL-17A+ and IL-22+ CD4+ T-cells | S-COPD (n=30) = HNS (n=10) |
Qiu, 2016 [30] | Flow cytometry | IL-17A+ CD4+ T-cells | S-COPD (n=38) > HS (n=20) = HNS (n=20) |
Solleiro, 2015 [31] | Flow cytometry | IL-17A+ CD4+ T-cells | TS-COPD (n=24) > BE-COPD (n=17) > HNS (n=20) |
Sun, 2016 [22] | Flow cytometry | IL-17A+ CD4+ T-cells | AE-COPD (n=24) > S-COPD (n=26) = HS (n=23) |
Vargas-Rojas, 2011 [32] | Flow cytometry | IL-17A+ CD4+ T-cells | S-COPD (n=39) > HS (n=14) = HNS (n=15) |
Wang, 2015 [23] | Flow cytometry | IL-17A+ CD4+ T-cells | S-COPD (n=65) > HS (n=35) > HNS (n=31)¶ |
Zhang, 2016 [34] | Flow cytometry | IL-17A+ CD4+ T-cells | S-COPD (n=29) > HS (n=24) = HNS (n=27) |
Paats, 2012 [29] | Flow cytometry | IL-17F+ CD4+ T-cells | S-COPD (n=30) > HNS (n=10) |
Paats, 2012 [29] | Flow cytometry | IL-17A+, IL-17F+ and IL-22+ CD8+ T-cells | S-COPD (n=30) = HNS (n=10) |
Xu, 2016 [33] | Flow cytometry | IL-17A+ CD8+ T-cells | S-COPD (n=25) > HS (n=23) = HNS (n=15) |
Data are presented as comparisons of cytokines levels or cells proportions in the blood of healthy nonsmokers (HNS), healthy smokers (HS) and patients with COPD. OPD-CB: obstructive pulmonary disease including chronic bronchitis; AE-COPD: acute exacerbation of COPD; S-COPD: stable COPD; HC: healthy controls without data on smoking status; TS-COPD: COPD related to tobacco smoking; BE-COPD: COPD related to biomass exposure. #: HNS is significantly different from OPD-CB, but HS is not significantly different from the two other groups; ¶: higher cytokine levels or cell proportions in severe/very severe COPD compared to mild/moderate COPD; §: IL-17A levels increase with COPD stages.